About Dual AAV
Dual AAV vectors split your gene into two vectors that under in-vivo homologous recombination, reforms to produce a full gene product. These are used when payloads >4.7kb are required.
Dual AAV vector controls contain two AAV vectors, with each vector carrying half of a GFP reporter gene. When recombined, a functional GFP is formed, allowing quick visual read-out.
Your team can use dual AAV vector controls to de-risk projects, for proof-of-principle studies, and to optimize parameters before moving into larger, more complex experiments. These controls are available in a wide range of promoters for tissue targeting.
Features
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
AAV-h-APOC4-shRNA
Cat No: shAAV-201197
Availability: 6-8 weeks
AAV-h-APOD-shRNA
Cat No: shAAV-201198
Availability: 6-8 weeks
AAV-h-APOE-shRNA
Cat No: shAAV-201199
Availability: 6-8 weeks
AAV-h-APOF-shRNA
Cat No: shAAV-201200
Availability: 6-8 weeks
AAV-h-APOH-shRNA
Cat No: shAAV-201201
Availability: 4-5 weeks
AAV-h-APOL1-shRNA
Cat No: shAAV-201203
Availability: 6-8 weeks
AAV-h-APOL2-shRNA
Cat No: shAAV-201208
Availability: 4-5 weeks
AAV-h-APOL3-shRNA
Cat No: shAAV-201209
Availability: 6-8 weeks
AAV-h-APOL4-shRNA
Cat No: shAAV-201211
Availability: 6-8 weeks
AAV-h-APOL5-shRNA
Cat No: shAAV-201212
Availability: 6-8 weeks
AAV-h-APOL6-shRNA
Cat No: shAAV-201213
Availability: 4-5 weeks
AAV-h-DDX47-shRNA
Cat No: shAAV-201215
Availability: 4-5 weeks
